News

NVO Stock Gains After Parvus Asset Management Builds Stake
Detailed price information for Bayer Aktienges ADR (BAYRY) from The Globe and Mail including charting and trades.
Can Mounjaro, Zepbound Help Lilly Maintain Dominance in Obesity Space?
Eli Lilly’s LLY key top-line drivers are its GLP-1 medicines, Mounjaro for type II diabetes and Zepbound for obesity. Both ...
Health Rounds: Patients drop fewer pounds with weight-loss drugs in real world than in trials
By Nancy Lapid (Reuters) -People who take weight-loss drugs hoping to achieve the impressive results observed in large ...
UNILAD21h
Doctors explain exactly what could happen to your body if you try 'golden dose' hack for Ozempic and Mounjaro that could be fatal
Doctors have explained what the 'golden dosing' trend does to your body as Ozempic and Mounjaro rise in popularity for weight ...
Devdiscourse22h
Real-World Weight-Loss Results vs. Clinical Trials: The Reality of Obesity Medications
A new study shows weight-loss drugs, such as Novo Nordisk's Wegovy and Eli Lilly's Mounjaro, yield lower weight reductions in ...
Should You Buy Eli Lilly Stock Before June 22?
Eli Lilly will be presenting data from studies on multiple GLP-1 drugs later this month. Eli Lilly (NYSE: LLY) stock hasn't ...
Novo Nordisk starts new CagriSema weightloss drug trial
Novo Nordisk has launched a new late-stage trial for its experimental next-generation obesity drug candidate, CagriSema, as ...
Hims & Hers says its weight-loss business can grow as US market changes
Hims & Hers Health is betting that the cash-pay market for weight-loss drugs will drive up customer demand although some ...
Devdiscourse1d
Novo Nordisk Sets New Benchmark with CagriSema Obesity Trial
Novo Nordisk has launched a late-stage trial for its obesity drug candidate, CagriSema, aiming to restore market confidence ...
Novo Nordisk Stock Climbs on Report of Activist Investor Parvus Building Stake
The U.S.-listed shares of Danish drugmaker Novo Nordisk rose Tuesday following a report that an activist investor is building ...
Weight-loss drugs were said to be a game changer. Turns out the benefit might be thinner than thought
Lastly, the researchers observed that while patients who discontinued obesity medications lost significantly less weight ...
New fat jabs warning over ‘increased risk of cancer – as experts fear they ‘stop common medication working’
WEIGHT loss jabs could prevent a medication taken by millions of women from working – and increase patients’ risk of cancer. The British Menopause Society said the jabs could cause ...